Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18


The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.

Vegting Y, Reneman L, Booij J.

Psychopharmacology (Berl). 2016 Oct;233(19-20):3473-501. doi: 10.1007/s00213-016-4396-5. Epub 2016 Aug 28. Review.


The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the Literature.

Hellem T, Shi X, Latendresse G, Renshaw PF.

J Am Psychiatr Nurses Assoc. 2015 Jul-Aug;21(4):244-75. doi: 10.1177/1078390315598606. Review.


3,4-methylenedioxymethamphetamine (MDMA): current perspectives.

Meyer JS.

Subst Abuse Rehabil. 2013 Nov 21;4:83-99. doi: 10.2147/SAR.S37258. eCollection 2013. Review.


Brain damages in ketamine addicts as revealed by magnetic resonance imaging.

Wang C, Zheng D, Xu J, Lam W, Yew DT.

Front Neuroanat. 2013 Jul 17;7:23. doi: 10.3389/fnana.2013.00023. eCollection 2013.


Decision-making in polydrug amphetamine-type stimulant users: an fMRI study.

Koester P, Volz KG, Tittgemeyer M, Wagner D, Becker B, Gouzoulis-Mayfrank E, Daumann J.

Neuropsychopharmacology. 2013 Jul;38(8):1377-86. doi: 10.1038/npp.2013.43. Epub 2013 Feb 7.


Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?

Mackey S, Paulus M.

Neurosci Biobehav Rev. 2013 Mar;37(3):300-16. doi: 10.1016/j.neubiorev.2012.12.003. Epub 2012 Dec 17. Review.


Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research.

Crunelle CL, Veltman DJ, Booij J, Emmerik-van Oortmerssen K, van den Brink W.

Brain Behav. 2012 Jul;2(4):499-523. doi: 10.1002/brb3.65. Epub 2012 Jun 26.


MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus.

Anneken JH, Gudelsky GA.

Neuropharmacology. 2012 Nov;63(6):1022-7. doi: 10.1016/j.neuropharm.2012.07.026. Epub 2012 Jul 25.


Methodological weaknesses in non-randomized studies of ecstasy (MDMA) use: a cautionary note to readers and reviewers.

Krebs TS, Johansen PØ.

Neuropsychopharmacology. 2012 Mar;37(4):1070-1; author reply 1072-3. doi: 10.1038/npp.2011.202. No abstract available.


MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.

Salomon RM, Karageorgiou J, Dietrich MS, McLellan JY, Charboneau EJ, Blackford JU, Cowan RL.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):41-7. doi: 10.1016/j.drugalcdep.2011.06.022. Epub 2011 Jul 31.


Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.

Tai YF, Hoshi R, Brignell CM, Cohen L, Brooks DJ, Curran HV, Piccini P.

Neuropsychopharmacology. 2011 Mar;36(4):735-43. doi: 10.1038/npp.2010.201. Epub 2010 Dec 15.


MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain.

Perrine SA, Ghoddoussi F, Michaels MS, Hyde EM, Kuhn DM, Galloway MP.

Neurotoxicology. 2010 Dec;31(6):654-61. doi: 10.1016/j.neuro.2010.08.005. Epub 2010 Aug 26.


Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.

Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, Warsh JJ, Boileau I.

Brain. 2010 Jun;133(Pt 6):1779-97. doi: 10.1093/brain/awq103. Epub 2010 May 17.


Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.

Licata SC, Renshaw PF.

Ann N Y Acad Sci. 2010 Feb;1187:148-71. doi: 10.1111/j.1749-6632.2009.05143.x. Review.


Sleep apnea in young abstinent recreational MDMA ("ecstasy") consumers.

McCann UD, Sgambati FP, Schwartz AR, Ricaurte GA.

Neurology. 2009 Dec 8;73(23):2011-7. doi: 10.1212/WNL.0b013e3181c51a62. Epub 2009 Dec 2.


Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users.

McCann UD, Wilson MJ, Sgambati FP, Ricaurte GA.

J Neurosci. 2009 Nov 4;29(44):14050-6. doi: 10.1523/JNEUROSCI.4654-09.2009.


Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.

Gouzoulis-Mayfrank E, Daumann J.

Dialogues Clin Neurosci. 2009;11(3):305-17. Review.


Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.

Karageorgiou J, Dietrich MS, Charboneau EJ, Woodward ND, Blackford JU, Salomon RM, Cowan RL.

Neuroimage. 2009 Jul 1;46(3):817-26. doi: 10.1016/j.neuroimage.2009.02.029. Epub 2009 Mar 2.

Supplemental Content

Support Center